Farallon Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,300,000
Closed -$1.65B 135
2020
Q1
$1.65B Buy
9,300,000
+1,310,000
+16% +$247M 14.14% 1
2019
Q4
$1.53B Buy
7,990,000
+1,755,000
+28% +$317M 10.31% 1
2019
Q3
$1.05B Buy
6,235,000
+5,235,000
+524% +$853M 7.92% 2
2019
Q2
$167M Buy
+1,000,000
New +$138M 1.09% 27
2017
Q3
Sell
-227,500
Closed -$55.3M 98
2017
Q2
$55.3M Sell
227,500
-420,000
-65% -$98.7M 0.57% 36
2017
Q1
$155M Sell
647,500
-307,500
-32% -$71.6M 1.7% 21
2016
Q4
$201M Sell
955,000
-45,000
-5% -$9.32M 2.31% 13
2016
Q3
$230M Buy
1,000,000
+349,600
+54% +$85.4M 3.37% 6
2016
Q2
$150M Sell
650,400
-512,100
-44% -$118M 2.07% 13
2016
Q1
$312M Sell
1,162,500
-112,500
-9% -$32.2M 2.98% 7
2015
Q4
$398M Buy
1,275,000
+380,589
+43% +$113M 3.55% 6
2015
Q3
$243M Sell
894,411
-24,873
-3% -$7.64M 3.21% 5
2015
Q2
$279M Sell
919,284
-66,000
-7% -$19.7M 3.75% 6
2015
Q1
$293M Buy
985,284
+919,914
+1,407% +$262M 4.28% 4
2014
Q4
$16.8M Buy
+65,370
New +$16.3M 0.23% 61
2014
Q1
Sell
-657,000
Closed -$110M 104
2013
Q4
$110M Buy
+657,000
New +$103M 2.29% 18

Other funds holding AGN

Farallon Capital Management's AGN Position: Q2 2020 in Review

Farallon Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 9,300,000 shares — an estimated $1.65B sold.

Farallon Capital Management first reported a position in AGN in Q4 2013 and held it in 16 quarters. The position peaked at $1.65B in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Farallon Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Farallon Capital Management sold 9,300,000 Allergan plc shares in Q2 2020, an estimated $1.65B.
  • Farallon Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 16 quarters.
  • Farallon Capital Management's Allergan plc position peaked at $1.65B in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Farallon Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.